257 related articles for article (PubMed ID: 22342807)
1. New and future immunomodulatory therapy in type 1 diabetes.
Tooley JE; Waldron-Lynch F; Herold KC
Trends Mol Med; 2012 Mar; 18(3):173-81. PubMed ID: 22342807
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.
Waldron-Lynch F; Herold KC
Nat Rev Drug Discov; 2011 Jun; 10(6):439-52. PubMed ID: 21629294
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress in beta cells and autoimmune diabetes.
Clark AL; Urano F
Curr Opin Immunol; 2016 Dec; 43():60-66. PubMed ID: 27718448
[TBL] [Abstract][Full Text] [Related]
4. [Immunological intervention to preserve beta-cell function in type 1 diabetes].
Schloot NC
Dtsch Med Wochenschr; 2010 May; 135(18):915-21. PubMed ID: 20425677
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in autoimmune type 1 diabetes.
Weigmann B; Franke RK; Daniel C
Rev Diabet Stud; 2012; 9(2-3):68-81. PubMed ID: 23403703
[TBL] [Abstract][Full Text] [Related]
6. Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results.
Eldor R; Kassem S; Raz I
Diabetes Metab Res Rev; 2009 May; 25(4):316-20. PubMed ID: 19267355
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
8. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
Shekhar C
Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
[No Abstract] [Full Text] [Related]
9. Mesenchymal stem cells moderate immune response of type 1 diabetes.
Xv J; Ming Q; Wang X; Zhang W; Li Z; Wang S; Li Y; Li L
Cell Tissue Res; 2017 May; 368(2):239-248. PubMed ID: 27726027
[TBL] [Abstract][Full Text] [Related]
10. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.
Mabed M; Shahin M
Curr Stem Cell Res Ther; 2012 May; 7(3):179-90. PubMed ID: 22023626
[TBL] [Abstract][Full Text] [Related]
12. Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes.
Couri CE; Voltarelli JC
Curr Stem Cell Res Ther; 2011 Mar; 6(1):10-5. PubMed ID: 20955160
[TBL] [Abstract][Full Text] [Related]
13. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.
Azam A; Eisenbarth GS
Expert Opin Biol Ther; 2004 Oct; 4(10):1569-75. PubMed ID: 15461568
[TBL] [Abstract][Full Text] [Related]
15. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
16. The challenge of modulating β-cell autoimmunity in type 1 diabetes.
Atkinson MA; Roep BO; Posgai A; Wheeler DCS; Peakman M
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):52-64. PubMed ID: 30528099
[TBL] [Abstract][Full Text] [Related]
17. Targeting Type 1 Diabetes: Selective Approaches for New Therapies.
Sheehy DF; Quinnell SP; Vegas AJ
Biochemistry; 2019 Jan; 58(4):214-233. PubMed ID: 30608114
[TBL] [Abstract][Full Text] [Related]
18. Prevention of type 1 diabetes.
Thrower SL; Bingley PJ
Br Med Bull; 2011; 99():73-88. PubMed ID: 21725084
[TBL] [Abstract][Full Text] [Related]
19. Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus.
Fenske RJ; Kimple ME
Exp Biol Med (Maywood); 2018 Mar; 243(6):586-591. PubMed ID: 29504478
[TBL] [Abstract][Full Text] [Related]
20. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
